Evidence map›Paper›PMID 35048211›Full record

ArticleParasitology research2022

Brazilian green propolis reduces worm burden and hepatic granuloma formation in a Schistosoma mansoni experimental murine model.

Lucas A de L Paula, Mário F C Santos, Mariana C Pagotti, Rodrigo C S Veneziani, Jairo K Bastos, Conor R Caffrey, Sérgio R Ambrósio, Lizandra G Magalhães

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. StandardizedPathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Lucas A de L PaulaResearch Group on Natural Products, Center for Research in Sciences and Technology, University of Franca, Avenida Dr. Armando Salles de Oliveira, 201, SP, CEP 14404-600, Franca, Brazil.
Mário F C SantosResearch Group on Natural Products, Center for Research in Sciences and Technology, University of Franca, Avenida Dr. Armando Salles de Oliveira, 201, SP, CEP 14404-600, Franca, Brazil.
Mariana C PagottiResearch Group on Natural Products, Center for Research in Sciences and Technology, University of Franca, Avenida Dr. Armando Salles de Oliveira, 201, SP, CEP 14404-600, Franca, Brazil.
Rodrigo C S VenezianiResearch Group on Natural Products, Center for Research in Sciences and Technology, University of Franca, Avenida Dr. Armando Salles de Oliveira, 201, SP, CEP 14404-600, Franca, Brazil.
Jairo K BastosSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café, s/n, CEP 14.040-903, Ribeirão Preto, SP, Brazil.
Conor R CaffreyCenter for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
Sérgio R AmbrósioResearch Group on Natural Products, Center for Research in Sciences and Technology, University of Franca, Avenida Dr. Armando Salles de Oliveira, 201, SP, CEP 14404-600, Franca, Brazil. sergio.ambrosio@unifran.edu.br.
Lizandra G MagalhãesResearch Group on Natural Products, Center for Research in Sciences and Technology, University of Franca, Avenida Dr. Armando Salles de Oliveira, 201, SP, CEP 14404-600, Franca, Brazil. lizandra.magalhaes@unifran.edu.br.ORCID http://orcid.org/0000-0003-2959-6752
Universidade de Franca · BRUniversidade de São Paulo · BRUniversity of California San Diego · US

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 303946/2018-0Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88882.365793/2019-01Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/04138-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/05020-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/05080-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/25010-2Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/50011-2
6 · The paper itself

Abstract

Characterized as an acute and chronic parasitic disease, schistosomiasis mansoni has as its central pathology the formation of hepatic granulomas in response to the parasite's eggs trapped in the host's liver. In recent years, research on propolis has grown; however, there is little anthelmintic work on this bee product. In the propolis scenario, Brazilian ones receive attention, with green and red propolis standing out. This study aims to evaluate in vivo the standardized extract of Brazilian green propolis (Pex) against Schistosoma mansoni. The in vivo antiparasitic activity of Pex was conducted in female BALB/c mice infected with S. mansoni and of the three groups treated with Pex (300 mg/kg); G2 (35th to 42nd dpi) reduced the total worm burden by 55.32%, followed by G3 (42nd to 49th dpi) and G4 (49th to 56th dpi), with about 46%. Furthermore, G2 significantly reduced the total egg load in the ileum (59.33%) and showed an increase in the dead eggs. Similarly, histological analysis of the livers showed a significant reduction in the number and diameter of the granulomas. Based on these results, there is an interesting schistosomicidal activity of Pex and its potential against the formation of hepatic granulomas, paving the way for more detailed studies of propolis in the animal model of schistosomiasis mansoni.

Indexed as

PropolisSchistosomiasis mansoniAnimalsDisease Models, AnimalFemaleGranulomaLiverMiceMice, Inbred BALB CSchistosoma mansoniPropolisBrazilian green propolisSchistosoma mansoniSchistosomicidal

Identifiers

PMID35048211
OpenAlexW4206141767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.